comparemela.com

Latest Breaking News On - கண்டுபிடிப்பு மண்டபம் - Page 9 : comparemela.com

À Montpellier, la plupart des start-up ont plutôt bien résisté

À Montpellier, la plupart des start-up ont plutôt bien résisté
midilibre.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from midilibre.fr Daily Mail and Mail on Sunday newspapers.

Digital signage future trends: touchless takes charge in 2021

Digital signage future trends: touchless takes charge in 2021 If there is any technology that made a big splash in the digital signage and self-service industry, it s touchless. From gesture control to virtual keyboards, these individual solutions have helped retailers, museums and other businesses adapt to the demands of COVID-19 and will continue to dominate this year. Photo: provided If there is any technology that made a big splash in the digital signage and self-service industry, it s touchless. From gesture control to virtual keyboards, these individual solutions have helped retailers, museums and other businesses adapt to the demands of COVID-19. For example, the Galt Museum and Archives in Alberta, Canada, needed a way for users to activate touchscreens at exhibits without directly touching any screens, and touchless technology came to its rescue.

DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and

Press release content from Globe Newswire. The AP news staff was not involved in its creation. DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and . DIACCURATEJanuary 12, 2021 GMT Dr. Dominique BRIDON leads the new entity DIACCURATE is now developing 3 programs in cancer and immunotherapy DIACCURATE will be initiating a first clinical trial by early 2022 Paris, France, January 12, 2021 By acquiring BIOKINESIS, a French biotech that develops the very first anticancer compound targeting the Golgi apparatus, DIACCURATE comforts its “sole-in-class” therapeutic strategy in oncology and immunotherapy. The company is developing a new generation of drug candidates which relies on novel mechanisms of action and untapped cellular and subcellular compartments. Initial data already suggest that this highly innovative approach could help to improve resitance to cancer progression and extend the benefits of immunotherapy to more indications and pati

上海外資40年|霍尼韋爾:上海吸引外企投資經營有3大優勢

上海外資40年|霍尼韋爾:上海吸引外企投資經營有3大優勢
sina.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.tw Daily Mail and Mail on Sunday newspapers.

New Development for Cross-Sector Innovation and Advanced Technology Collaboration in Oklahoma City Innovation District, Gardner Tanenbaum and Robinson Park Investments

New Development for Cross-Sector Innovation and Advanced Technology Collaboration in Oklahoma City Innovation District, Gardner Tanenbaum and Robinson Park Investments
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.